Bismuth add-on improves the efficacy of 2-week tegoprazan-based triple therapy for first-line Helicobacter pylori eradication: a real-world evidence study.
Jun-Hyung ChoPublished in: Expert review of anti-infective therapy (2024)
The bismuth add-on increased the first-line H. pylori eradication rate of 2-week TPZ-based triple therapy.